Platinum designation by the Business Group on Health in 2022 and 2023

Best Employer: Excellence in Health and Well-being

Named in Fortune Magazine's list of best companies to work for

Fortune's 100 Best Companies

Fortune's Most Admired Companies

Global development and commercialization collaboration for three DXd ADCs (antibody-drug conjugates)

Daiichi Sankyo Collaboration

Initiative to support early-stage biomedical startups developing AI and machine learning applications for drug discovery and development

Merck Digital Sciences Studio (MDSS)

Initiative to fund and collaborate with entrepreneurs and early-stage companies focused on delivering transformative healthcare technologies in Asia Pacific and Europe

IDEA Studios

Ongoing research and development efforts related to COVID-19 treatments and vaccines

COVID-19 Research and Response

MSD (United States), also known as Merck & Co., is a multinational pharmaceutical company with over 130 years of history. The company invested $12.2 billion in R&D in 2021. Its research network includes hubs in New Jersey, Pennsylvania, Massachusetts, and California. MSD uses AI, machine learning, and data science to accelerate drug discovery and development, focusing on oncology, vaccines, infectious diseases, immunology, and neuroscience. The Merck Digital Sciences Studio and IDEA Studios support early-stage biomedical startups.

Rahway, NJ (World Headquarters)

West Point, PA

Boston, MA

Cambridge, MA

South San Francisco, CA

San Diego, CA

Upper Gwynedd, PA

London, UK

Singapore

Merck Research Laboratories is MSD's central R&D organization, with major sites in New Jersey, Pennsylvania, Massachusetts, and California. It focuses on drug discovery and development across various therapeutic areas, including oncology, vaccines, infectious diseases, immunology, and neuroscience.

Merck Research Laboratories

KEYTRUDA® is MSD's leading anti-PD-1 therapy, approved for the treatment of various types of cancer, including melanoma, lung cancer, and head and neck cancer. It has been a significant contributor to MSD's oncology portfolio and a key focus of the company's research efforts.

KEYTRUDA® (pembrolizumab)

$12.2 billion invested in research and development as of 2021

Internal R&D Investment

Plans to invest $38 million across Asia Pacific and Europe over three years through IDEA Studios

MSD Global Health Innovation Fund (MGHIF)

Robert M. Davis

Dean Y. Li, M.D., Ph.D.

Steve Mizell

Dave Williams

Recognition as one of the best employers in America

Forbes America's Best Employers (2023)

Listed among the world's most admired companies

Fortune World's Most Admired Companies (2023)

Recognized for high number of patent grants

Top 5 in patent grants 2024

Recognized as a top employer for new graduates

America's Best Employers for New Grads by Forbes

America's Greatest Workplaces for Diversity by Newsweek

Listed among the best workplaces in the biotech industry

Best Places to Work by Biospace

Collaboration on AI-driven drug discovery

Generate Biomedicines

Novartis

BeiGene

Partnership on immune sequencing technology

Adaptive Biotechnologies

Development of targeted therapy for specific cancer mutations

AMG 510 (Lumakras) for KRAS G12C-mutated cancers

Ongoing development and application of Repatha for cardiovascular health

Repatha for cardiovascular disease

Continued development and application of Evenity for bone health

Evenity for osteoporosis

Utilizing AI and machine learning for innovative drug discovery

Generative biology approaches for protein therapeutic discovery

Advancing Bispecific T-cell Engager technology for cancer treatment

BiTE Technology Innovation

Integrating AI and machine learning for more efficient and effective clinical trials

AI-Driven Clinical Trial Innovation

Amgen, a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics. The company focuses on understanding human biology and addressing unmet medical needs. Its second-largest R&D facility focuses on therapeutics for serious illnesses. Amgen scientists integrate AI and advanced computing to enhance drug discovery, improve clinical trials, and increase efficiency. Their work ranges from studying DNA to working with patients in clinical trials.

One Amgen Center Drive, Thousand Oaks, CA 91320

Global Headquarters

Amgen Manufacturing Limited

Cambridge Research Center

750 Gateway Blvd., Suite 100, South San Francisco, CA 94080

South San Francisco Facility

40 Technology Way, West Greenwich, RI 02817

West Greenwich Facility

The Lighthouse Building, Telecomlaan 5-7, Ave Télécom, 1831 Diegem

European Headquarters

Reykjavik Facility

Munich Office

Singapore Manufacturing

Amgen Technology Private Limited, 10-01, 10th Floor, C Wing, Nesco IT Park, Western Express Highway, Goregaon (E), Mumbai, Maharashtra 400 063

Mumbai Office

Rochaverá Corporate Towers, Torre Crystal, Avenida das Nações Unidas 14.171, 22° andar CEP: 04794-000, Santo Amaro

São Paulo Office

This lab focuses on integrating AI, machine learning, and advanced computing techniques to enhance various aspects of drug discovery and development, such as target identification, lead optimization, and clinical trial design.

Amgen

Overview

Video

Featured Content

Amgen Computational Biology and Genomics Lab

Research Areas

R&D 100 Awards

New design for syringes

Publications per Year

Patents per Year

Related Content

Howard University and Amgen create Academia-Biotech Educational Fellowship

Explore More Labs